Is kisqali chemotherapy?

See the DrugPatentWatch profile for kisqali

Kisqali is not chemotherapy.

Kisqali (ribociclib) is an oral targeted therapy used to treat certain types of hormone-receptor–positive, HER2-negative advanced or metastatic breast cancer. It works by inhibiting CDK4/6 (cyclin-dependent kinases), which slows cancer-cell growth. [1]

Chemotherapy, by contrast, uses drugs that kill rapidly dividing cells more broadly and typically includes combinations given in cycles.

If you tell me the specific Kisqali regimen (for example, with an aromatase inhibitor or fulvestrant) or the cancer stage, I can explain what role it plays compared with other treatments in that plan.

Sources:
[1] https://www.drugs.com/kisqali.html